Detection of inhaled salbutamol in equine urine by ELISA and GC/MS2

Biomedical Chromatography

Volumn 16, Issue 8, 2002, Pages 513-516

  Van Eenoo, P ^a   Delbeke, Frans T ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; PULMONARY DISEASES;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; CONFIRMATORY ANALYSIS; DETECTION TIME; HORSE URINE; HUMAN USE; METERED-DOSE INHALERS; PROPERTY; SALBUTAMOL; THERAPEUTIC DOSE; VENTOLIN;

PHASE SEPARATION;

BAMBUTEROL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; FENOTEROL; FORMOTEROL; SALBUTAMOL; SALMETEROL XINAFOATE; TERBUTALINE;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; DOPING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG URINE LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUIPMENT DESIGN; GAS CHROMATOGRAPHY; HORSE; METERED DOSE INHALER; NONHUMAN; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION PROCESS;

EQUIDAE; EQUUS CABALLUS;

EID: 0036920247     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.194     Document Type: Article

References (15)

1. AORC. Minimum performance criteria for chromatography and mass spectrometry, internal communication. The Association of Official Racing Chemists, 2002.
2. Bergés R, Segura J, de la Torre X and Ventura RJ. Analytical methodology for enantiomers of salbutamol in human urine for application in doping control. Journal of Chromatography B 1999; 723: 173-184.
3. Derksen FJ. Olszewski MA, Robinson NE, Berney C, Hakala JE, Matson CJ and Ruth DT. Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. American Journal of Veterinary Research 1999: 60: 689-693.
4. Eurachem Guide. The fitness for purpose of analytical methods. A laboratory guide to method validation and related topics, 1998.
5. ICH 2QB. Validation of analytical procedures: methodology. International Conference on Harmonization (ICH), 1996.
6. IFHA. International Agreement on Breeding and Racing and Appendixes, International Federation of Horse Racing Authorities, January 2002.
7. ILAC-G7. Accreditation requirements and operating criteria for horseracing laboratories; www.ilac.org/, 1996.
8. IOC. Analytical Criteria for Reporting Low Concentrations of Anabolic Steroids, internal communication. International Olympic Committee, Lausanne, 1998.
9. IOC. List of Prohibited Substances, International Olympic Committee, Lausanne, 2002.
10. Jiménez C, Ventura R and Segura J. Validation of qualitative chromatogortaphic methods: strategy in antidoping control laboratories. Journal of Chromatography B 2002; 767: 341-351.
11. Mair TS and Derksen FJ. Chronic obstructive pulmonary disease: a review. Equine Veterinary Education 2000; 12: 35-44.
12. Saleh MI. Koh YM, Tan SC and Aishah AL. Clean-up, detection and determination of salbutamol in human urine and serum. Analyst 2000; 125: 1569-1572.
13. 2-agonists in urine by gas chromatography-mass spectrometry for application in doping control. Analytica Chimica Acta 2000; 418: 79-92.
14. Votion D, Ghafir Y, Munsters K, Duvivier DH. Art T and Lekeux, Aerosol deposition in equine lungs following ultrasonic nebulisation versus jet aerosol delivery system. Equine Veterinary Journal 1997; 29: 388-393.
15. Wynne PM, Batty DC, Vine JH and Simpson NJK. Reduced blocking rates through application of a new NC-SPE sorbent to the extraction of equine urine. In Proceedings of the 13th International Conference of Racing Analysts and Veterinarians, Williams RB, Houghton E and Wade J (eds) R&W Publications: Cambridge, 2000; 445-452.